Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Events

  Events

August 2013
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
ICMGP 2013 11th International Conference on Mercury as a Global Pollutant
28 Jul 2013 - 02 Aug 2013
Edinburgh, Scotland
ICMGP 2013 11th International Conference on Mercury as a Global Pollutant
More information
05 Aug 2013 - 09 Aug 2013
Stockton, CA (near San Francisco, CA)
Mass Spectrometry Principles and Practice
More information
2nd eClinical Technology Summit
07 Aug 2013 - 08 Aug 2013
Philadelphia, PA, USA
2nd eClinical Technology Summit
More information
Cellular & Molecular Mechanisms of Toxicity
11 Aug 2013 - 16 Aug 2013
Andover, NH, USA
Cellular & Molecular Mechanisms of Toxicity
More information
4th World Congress on Diabetes & Metabolism
14 Aug 2013 - 16 Aug 2013
Chicago-North Shore, IL, USA
4th World Congress on Diabetes & Metabolism
More information
BioConference Live: Genetics and Genomics
21 Aug 2013 - 22 Aug 2013
Online event
BioConference Live: Genetics and Genomics
More information






Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters